Literature DB >> 12492768

Achieving gains beyond response.

E S Paykel1.   

Abstract

OBJECTIVE: To review adverse outcomes following response in treatment of depression.
METHOD: Review of published literature with particular emphasis on key papers.
RESULTS: Moderately high rates of relapse and recurrence are found in naturalistic follow-up studies of depressed patients receiving modern treatment. These are reduced but not abolished in controlled trials by continuation and maintenance treatment with antidepressants. Suicide rates in follow-up studies are much elevated compared with the general population. Social function is impaired and remits more slowly than depressive symptoms. A key outcome is the occurrence of incomplete remission with residual symptoms, which is associated with high relapse rates and impaired social function.
CONCLUSION: It is important to achieve complete remission in depression. Elimination of residual symptoms is an important target for full treatment of the depressive episode, in order to avoid later adverse outcomes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12492768     DOI: 10.1034/j.1600-0447.106.s415.3.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN: 0065-1591


  8 in total

Review 1.  Remission from depression : a review of venlafaxine clinical and economic evidence.

Authors:  Donald Han; Edward C Y Wang
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  Re-evaluation of the efficacy and tolerability of venlafaxine vs SSRI: meta-analysis.

Authors:  S Weinmann; T Becker; M Koesters
Journal:  Psychopharmacology (Berl)       Date:  2007-10-23       Impact factor: 4.530

Review 3.  New modalities of assessment and treatment planning in depression: the sequential approach.

Authors:  Giovanni A Fava; Elena Tomba
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

Review 4.  Neuromodulation therapies for geriatric depression.

Authors:  Verònica Gálvez; Kerrie-Anne Ho; Angelo Alonzo; Donel Martin; Duncan George; Colleen K Loo
Journal:  Curr Psychiatry Rep       Date:  2015-07       Impact factor: 5.285

5.  Twelve-month, prospective, open-label study of repetitive transcranial magnetic stimulation for major depressive disorder in partial remission.

Authors:  Chawanun Charnsil; Sirijit Suttajit; Vudhichai Boonyanaruthee; Samornsri Leelarphat
Journal:  Neuropsychiatr Dis Treat       Date:  2012-08-30       Impact factor: 2.570

6.  Poor response to treatment: beyond medication.

Authors:  César Carvajal
Journal:  Dialogues Clin Neurosci       Date:  2004-03       Impact factor: 5.986

Review 7.  The Long and Winding Road of Vagus Nerve Stimulation: Challenges in Developing an Intervention for Difficult-to-Treat Mood Disorders.

Authors:  Harold A Sackeim; Maxine Dibué; Mark T Bunker; A John Rush
Journal:  Neuropsychiatr Dis Treat       Date:  2020-12-14       Impact factor: 2.570

Review 8.  Clinical research challenges posed by difficult-to-treat depression.

Authors:  A John Rush; Harold A Sackeim; Charles R Conway; Mark T Bunker; Steven D Hollon; Koen Demyttenaere; Allan H Young; Scott T Aaronson; Maxine Dibué; Michael E Thase; R Hamish McAllister-Williams
Journal:  Psychol Med       Date:  2022-01-07       Impact factor: 7.723

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.